Paul Tudor Jones Kymera Therapeutics, Inc. Transaction History

Tudor Investment Corp Et Al

$15.5 Billion
Q1 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 46,373 shares of KYMR stock, worth $1.38 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

46,373

Holding current value

$1.38 Million

% of portfolio

0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$22.9 - $43.57 $1.06 Million - $2.02 Million	46,373 New	46,373 $1.86 Million
Q3 2023 Nov 15, 2023	SELL	$13.9 - $23.88 $346,471 - $595,232	-24,926 Reduced 47.73%	27,296 $379,000
Q2 2023 Aug 14, 2023	BUY	$22.4 - $34.92 $510,719 - $796,176	22,800 Added 77.49%	52,222 $1.2 Million
Q1 2023 May 15, 2023	BUY	$24.84 - $38.75 $33,981 - $53,010	1,368 Added 4.88%	29,422 $872,000
Q4 2022 Feb 14, 2023	BUY	$19.57 - $30.92 $101,587 - $160,505	5,191 Added 22.7%	28,054 $700,000

Q3 2022 Nov 14, 2022	SELL	$20.91 - $34.27 $385,768 - $632,247	-18,449 Reduced 44.66%	22,863 $498,000
Q2 2022 Aug 15, 2022	SELL	$14.13 - $42.55 $204,715 - $616,464	-14,488 Reduced 25.96%	41,312 $813,000
Q1 2022 May 16, 2022	BUY	$35.3 - $64.68 $1.08 Million - $1.98 Million	30,683 Added 122.16%	55,800 $2.36 Million
Q4 2021 Feb 14, 2022	BUY	$49.91 - $65.56 $1.25 Million - $1.65 Million	25,117 New	25,117 $1.6 Million
Q2 2021 Aug 16, 2021	SELL	$31.08 - $51.95 $172,245 - $287,906	-5,542 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$35.64 - $85.46 $374,612 - $898,270	-10,511 Reduced 65.48%	5,542 $215,000
Q4 2020 Feb 16, 2021	SELL	$28.07 - $87.83 $2.12 Million - $6.63 Million	-75,463 Reduced 82.46%	16,053 $995,000
Q3 2020 Nov 16, 2020	BUY	$26.1 - $33.28 $2.39 Million - $3.05 Million	91,516 New	91,516 $2.96 Million

Others Institutions Holding KYMR

# of Institutions

164

Shares Held

63.1M

Call Options Held

39.7K

Put Options Held

9.7K

View Full List

About Kymera Therapeutics, Inc.

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $1.63B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

More about KYMR

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account